Innocan Pharma's Collaboration with Freedom Farm
Innocan Pharma Corporation, known for its innovative approaches in biotechnology, has embarked on a heartwarming partnership with Freedom Farm. This sanctuary is dedicated to rescuing animals suffering from various conditions, particularly those cast aside by industrial farming due to their physical disabilities. Innocan is using its LPT-CBD injection to offer relief and enhance the quality of life of these animals.
Understanding the Impact of LPT-CBD
The long-acting injectable LPT-CBD, developed by Innocan, represents a significant advancement in pain relief options for animals like those at Freedom Farm. For instance, goats Billy and Dror, who arrived with severe joint issues and chronic pain, have benefited immensely from this treatment. The injection is administered subcutaneously every 6 to 9 weeks and has been instrumental in restoring their mobility and happiness.
Transformative Care for Injured Animals
Prior to the introduction of the LPT-CBD injection, Billy and Dror faced immense challenges due to their painful conditions. Their daily activities were drastically limited, and social interactions with other animals were nearly impossible. However, since receiving treatment, they have shown remarkable improvements, allowing them to live more fulfilling lives, playing and interacting without the debilitating pain that once held them back.
The Science Behind LPT-CBD
LPT-CBD uses a special liposomal drug delivery system designed to provide a prolonged release of synthetic CBD. This method aims to tackle chronic pain more effectively without the adverse effects typically associated with conventional pain medications.
A Vision for Compassionate Care
Meital Ben Ari, Co-Founder of Freedom Farm, expressed the profound changes witnessed in the lives of Billy and Dror, calling their transformation nearly miraculous. Innocan's Chief Executive Officer, Iris Bincovich, shared the company's commitment to inspiring a compassionate world through enhanced human-animal bonds and innovative pain management solutions. The success stories of these animals are a testament to the potential that science holds to make a positive difference in lives.
Strengthening Animal Welfare Through Innovation
Innocan is not only focusing on animal welfare but is also innovating within the pharmaceutical sector. Their advanced CBD-loaded liposome drug delivery platform is reshaping how chronic pain can be managed both in animals and humans alike. The company continuously emphasizes the importance of their research and development, further underscoring their potential to transform pain management across species.
Contact Innocan Pharma for More Information
If you wish to know more about Innocan Pharma and their cutting-edge solutions, please reach out to them. Iris Bincovich, CEO, is available for inquiries at +1 5162104025, +972-54-3012842, or +442037699377. You can also contact them via email at info@innocanpharma.com.
Frequently Asked Questions
What is Innocan Pharma's LPT-CBD injection?
Innocan Pharma's LPT-CBD is a long-acting injectable treatment designed to provide relief from chronic pain in animals.
How does LPT-CBD work?
This treatment utilizes a specialized liposomal delivery system to release synthetic CBD gradually, effectively managing pain.
What animals have benefited from this treatment?
Animals like Billy and Dror, two goats with severe skeletal deformities, have shown remarkable improvements with LPT-CBD treatment.
How often is the LPT-CBD injection administered?
The injection is given every 6 to 9 weeks to maintain pain relief and improve the animal's quality of life.
How can I learn more about Innocan Pharma?
For more information, you can contact Innocan Pharma directly or visit their official website.
